What Went Wrong in This Failed Biotech? –
[ad_1] The biotech industry is built on high stakes, long timelines, and even longer odds. But even in a field known for volatility, the news that Geron is laying off roughly one-third of its workforce stands out as a dramatic setback—or in many ways, the predictable consequence of a company that never quite delivered on its own…
